Literature DB >> 23017868

Update: studies of prepulse inhibition of startle, with particular relevance to the pathophysiology or treatment of Tourette Syndrome.

Neal R Swerdlow1.   

Abstract

Prepulse inhibition of the startle reflex (PPI) is an operational measure of sensorimotor gating, in which the motor response to an abrupt, intense stimulus is inhibited by a weak lead stimulus. PPI is reduced in several brain disorders, including Tourette Syndrome (TS); it is regulated by forebrain circuitry, including portions of the basal ganglia implicated in the pathophysiology of TS, and is also heritable and under strong genetic control. PPI has been the focus of numerous translational models, because it is expressed by most mammalian species, with remarkable conservation of response characteristics and underlying neural circuitry between rodents and primates. Several of these models have recently explored causative factors in TS - from genes to specific basal ganglia perturbations - as well as potential TS therapeutics, including novel pharmacological and neurosurgical interventions. With the focus on Comprehensive Behavioral Interventions for Tics (CBIT) in the evolving treatment model for TS, future studies might apply PPI as a predictive measure for CBIT response, or for identifying medications that might augment CBIT efficacy. In the end, a measure based on a simple pontine-based reflex will have limitations in its ability to explicate any complex behavioral phenotype.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23017868      PMCID: PMC3566359          DOI: 10.1016/j.neubiorev.2012.09.002

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  84 in total

1.  Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation.

Authors:  R J Carter; L A Lione; T Humby; L Mangiarini; A Mahal; G P Bates; S B Dunnett; A J Morton
Journal:  J Neurosci       Date:  1999-04-15       Impact factor: 6.167

Review 2.  Using animal models to develop therapeutics for Tourette Syndrome.

Authors:  Neal R Swerdlow; Ashley N Sutherland
Journal:  Pharmacol Ther       Date:  2005-06-20       Impact factor: 12.310

3.  Lower prepulse inhibition in children with the 22q11 deletion syndrome.

Authors:  Christina Sobin; Karen Kiley-Brabeck; Maria Karayiorgou
Journal:  Am J Psychiatry       Date:  2005-06       Impact factor: 18.112

Review 4.  Preclinical models relevant to Tourette syndrome.

Authors:  Neal R Swerdlow; Ashley N Sutherland
Journal:  Adv Neurol       Date:  2006

5.  The effects of dopamine agonists on prepulse inhibition in healthy men depend on baseline PPI values.

Authors:  Panos Bitsios; Stella G Giakoumaki; Sophia Frangou
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

6.  Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome.

Authors:  Paul S A Kalanithi; Wei Zheng; Yuko Kataoka; Marian DiFiglia; Heidi Grantz; Clifford B Saper; Michael L Schwartz; James F Leckman; Flora M Vaccarino
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-30       Impact factor: 11.205

7.  Impaired prepulse inhibition of acoustic startle in obsessive-compulsive disorder.

Authors:  Klaus Hoenig; Andrea Hochrein; Boris B Quednow; Wolfgang Maier; Michael Wagner
Journal:  Biol Psychiatry       Date:  2005-05-15       Impact factor: 13.382

8.  Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.

Authors:  Rebecca J Ralph; S Barak Caine
Journal:  J Pharmacol Exp Ther       Date:  2004-10-19       Impact factor: 4.030

9.  Separable noradrenergic and dopaminergic regulation of prepulse inhibition in rats: implications for predictive validity and Tourette Syndrome.

Authors:  Neal R Swerdlow; Michele J Bongiovanni; Laura Tochen; Jody M Shoemaker
Journal:  Psychopharmacology (Berl)       Date:  2006-04-01       Impact factor: 4.530

10.  Sensory modulation of the blink reflex in patients with blepharospasm.

Authors:  E Gómez-Wong; M J Martí; E Tolosa; J Valls-Solé
Journal:  Arch Neurol       Date:  1998-09
View more
  20 in total

1.  Histidine decarboxylase knockout mice, a genetic model of Tourette syndrome, show repetitive grooming after induced fear.

Authors:  Meiyu Xu; Lina Li; Hiroshi Ohtsu; Christopher Pittenger
Journal:  Neurosci Lett       Date:  2015-04-01       Impact factor: 3.046

Review 2.  What makes you tic? Translational approaches to study the role of stress and contextual triggers in Tourette syndrome.

Authors:  Sean C Godar; Marco Bortolato
Journal:  Neurosci Biobehav Rev       Date:  2016-12-08       Impact factor: 8.989

3.  Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice.

Authors:  Kyle A Williams; Jean-Dominique Gallezot; Vladimir Pogorelov; Lissandra Castellan Baldan; Maximiliano Rapanelli; Michael Crowley; George M Anderson; Erin Loring; Roxanne Gorczyca; Eileen Billingslea; Suzanne Wasylink; Kaitlyn E Panza; A Gulhan Ercan-Sencicek; Kuakarun Krusong; Bennett L Leventhal; Hiroshi Ohtsu; Michael H Bloch; Zoë A Hughes; John H Krystal; Linda Mayes; Ivan de Araujo; Yu-Shin Ding; Matthew W State; Christopher Pittenger
Journal:  Neuron       Date:  2014-01-08       Impact factor: 17.173

Review 4.  Influence of emotional states on inhibitory gating: animals models to clinical neurophysiology.

Authors:  Howard C Cromwell; Rachel M Atchley
Journal:  Behav Brain Res       Date:  2014-05-23       Impact factor: 3.332

5.  Ultrasonic vocalizations, predictability and sensorimotor gating in the rat.

Authors:  Emily S Webber; David E Mankin; Justin J McGraw; Travis J Beckwith; Howard C Cromwell
Journal:  Behav Brain Res       Date:  2013-07-11       Impact factor: 3.332

Review 6.  Immune-mediated animal models of Tourette syndrome.

Authors:  Mady Hornig; W Ian Lipkin
Journal:  Neurosci Biobehav Rev       Date:  2013-01-10       Impact factor: 8.989

7.  Brain mechanisms for prepulse inhibition in adults with Tourette syndrome: initial findings.

Authors:  Nazlee Zebardast; Michael J Crowley; Michael H Bloch; Linda C Mayes; Brent Vander Wyk; James F Leckman; Kevin A Pelphrey; James E Swain
Journal:  Psychiatry Res       Date:  2013-07-31       Impact factor: 3.222

8.  Puerarin ameliorates 3-nitropropionic acid-induced neurotoxicity in rats: possible neuromodulation and antioxidant mechanisms.

Authors:  Heba M Mahdy; Mohamed R Mohamed; Manal A Emam; Amr M Karim; Ashraf B Abdel-Naim; Amani E Khalifa
Journal:  Neurochem Res       Date:  2013-12-18       Impact factor: 3.996

9.  Relationships among parvalbumin-immunoreactive neuron density, phase-locked gamma oscillations, and autistic/schizophrenic symptoms in PDGFR-β knock-out and control mice.

Authors:  Tomoya Nakamura; Jumpei Matsumoto; Yusaku Takamura; Yoko Ishii; Masakiyo Sasahara; Taketoshi Ono; Hisao Nishijo
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

10.  The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans.

Authors:  G M Leggio; S A Torrisi; R Mastrogiacomo; D Mauro; M Chisari; C Devroye; D Scheggia; M Nigro; F Geraci; N Pintori; G Giurdanella; L Costa; C Bucolo; V Ferretti; M A Sortino; L Ciranna; M A De Luca; M Mereu; F Managò; S Salomone; F Drago; F Papaleo
Journal:  Mol Psychiatry       Date:  2019-09-06       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.